Effect of scFOS on Increase in Stool Frequency in Constipated People
Functional ConstipationHealthyThe study aims to evaluate the effects of short-chain fructo-oligosaccharides on the frequency and consistency of stools in subjects with functional constipation.
Effect of Perilla Extract on Improvement on Gastrointestinal Discomfort
Abdominal Pain/ DiscomfortSlightly ConstipationIn the current study the effects of proprietary Perilla frutescens leaf extract in comparison to Maltodextrin, a fully digestible carbohydrate (placebo control), on gastrointestinal discomfort and bowel function were investigated. The study was performed double-blind and placebo-controlled with a 4 week intervention period. Study products were taken two times daily (each one capsule before breakfast and dinner).
Effects of scFOS on Stool Frequency in People With Functionnal Constipation
Functional ConstipationThe study aims to evaluate the effects of short-chain fructo-oligosaccharides on the frequency and constistency of stools in subjects with functional constipation
Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome...
Irritable Bowel SyndromeThe general aim of the current study is to describe the effect of pregabalin on colonic and sensory functions in adults with constipation predominant irritable bowel syndrome (IBS-C). Study hypotheses: Single-dose pregabalin 200mg increases sensation thresholds and decreases sensation ratings in response to balloon distension in the colon relative to pre-pregabalin treatment. Single-dose pregabalin 200 mg will increase colonic compliance and decrease colonic pain and gas thresholds in patients with irritable bowel syndrome constipation predominant. Single-dose pregabalin 200mg increases the colonic phasic and tonic response to a standardized meal.
Effect of the Consumption of a Cheese Enriched With Probiotic Organisms in Improving Symptoms of...
ConstipationConstipation is a common gastrointestinal motility disorder, chronic condition that often negatively affects the daily lives of patients due to their symptoms, such as infrequent stools, hard stools, straining or painful defecation, cramping, bloating and flatulence. Stress, poor diet and sedentary lifestyle are part of modern lifestyle, which contributes to the onset of constipation. One way to reduce constipation through nutritional management of affected individuals is through consumption of probiotic products, which beneficially affect the development of microbial flora in the intestine, helping to improve the symptoms of constipation. Among these foods, the market is a fresh cheese, plus Bifidobacterium lactis, which according to its maker, when consumed as part of a healthy diet, presents beneficial effects in improving symptoms of constipation. Hypothesis: The fresh cheese enriched with Bifidobacterium lactis relieves symptoms constipation.
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel...
ConstipationImpaction3 moreThis partially randomized clinical trial studies surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction. Bowel obstruction is a common problem for advanced cancer patients and can negatively affect quality of life. It is not yet known whether surgery or non-surgical management is the best treatment option for bowel obstruction and can lead to better quality of life.
Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118...
Drug Induced ConstipationStudy in healthy volunteers to investigate the effects of Rifampin on the Pharmacokinetics of NKTR-118.
Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults...
ConstipationGastrointestinal DisorderTo determine if Bifidobacterium lactis HN109 improves transit time and gastrointestinal symptoms in adults with constipation.
Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation
Functional ConstipationA randomized, double-blind/open-label, placebo/active-controlled, single/multiple dose, parallel, phase 1/2a trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of YH12852 in healthy subjects and patients with functional constipation
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
Postoperative ComplicationsConstipationThis is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 following administration of ascending multiple oral doses to healthy subjects.